BioSpace News Archive

Biotech Beach

Avid Bioservices Enters into Contract Manufacturing Agreements with New and Existing Customers

Company Signs Top Ten Global Pharmaceutical Company as New Client and Expands Relationship with Existing Biotechnology Company Customer

July 8, 2019
·
3 min read
Policy

Trump Plans New ‘Favored Nations Clause’ to Tie Drug Prices to the Cost Other Nations Pay

The executive order will demand that drugs purchased by the federal government will not cost more than the lowest price paid by other nations.

July 8, 2019
·
2 min read
·
Alex Keown
Drug Development

Triplet-targeted therapy improves survival for patients with advanced colorectal cancer and BRAF mutations

The three-drug combination of encorafenib, binimetinib and cetuximab significantly improved overall survival in patients with BRAF-mutated metastatic colorectal cancer, according to results of the BEACON CRC Phase III clinical trial led by researchers at The University of Texas MD Anderson Cancer Center.

July 8, 2019
·
5 min read
Drug Development

sterna biologicals Strengthens Management Team to Progress Towards Phase IIB Development

sterna biologicals GmbH & Co. KG (sterna) announced that the Company has recently appointed Dr. Marion Wencker as consulting Chief Medical Officer and Dr. Thomas Klaue as consulting Chief Financial Officer.

July 8, 2019
·
3 min read
Business

Skyhawk Therapeutics Partners with Merck to Discover and Develop RNA-Binding Molecules

Skyhawk and Merck will partner to discover and develop innovative RNA-binding small molecules that can form treatments for neurological diseases and cancer.

July 8, 2019
·
2 min read
·
Alex Keown
Deals

Roche’s $4.8 Billion Acquisition of Spark Pushed Back to April 2020

Roche and Spark initially agreed to the acquisition in February of this year. The deal has had mutiple delays due to regulatory scrutiny.

July 8, 2019
·
2 min read
·
Alex Keown
Drug Development

Da Volterra Announces Completion of Patient Recruitment for its Phase 2 Clinical Study with DAV132, a Novel Microbiota Protective Therapy

Da Volterra, a clinical-stage biopharmaceutical company developing new therapeutics to protect the intestinal microbiota, announced the completion of patient recruitment for its Phase 2 trial ‘SHIELD’ evaluating DAV132 in patients receiving antibiotics.

July 8, 2019
·
2 min read
Drug Development

GamaMabs Pharma announces presentation of murlentamab phase 2 study results in colorectal cancer at ESMO World Congress on Gastrointestinal Cancer

Longer than expected PFS for murlentamab when combined with FTD/TPI, particularly in patients with medium/high AMHRII expression, along with immune cascade activation in the tumor micro-environment

July 8, 2019
·
4 min read
Business

Immatics Appoints Harpreet Singh as Chief Executive Officer

Immatics Biotechnologies GmbH announced that Harpreet Singh has been appointed the Company’s Chief Executive Officer.

July 8, 2019
·
4 min read
PHARMASEAL Launches Second Major Release of EngilityÔ CTMS

PHARMASEAL, a new provider of clinical trial management and governance solutions to enter the market, announces a second major release of its EngilityÔ CTMS platform.

July 8, 2019
·
2 min read